CUSTOM STUDIES

I

II

III

Pk

IV & V

Study type

First In Man

First In Man

Safety

Pharmaco-kinetic

Global Pivotal Trials

Sample size

30

100

90

~3000

Status

3 Year Follow-Up Complete

2 Year Follow-Up Complete

1 Year Follow-Up Complete

6 Month Follow-Up Complete

Planned